EyePoint Executive Compensation (FY25)
EYPT · Executive and director compensation, fiscal 2024 to 2025
The EyePoint brief, $1,500
Positioning against its disclosed peers, the governance read, incentive design, and the CD&A alignment analysis; the full peer table; a committee-ready PDF.
From $1,200 for the board report; $2,400 for both.
Data as of September 7, 2026Latest filing (8-K): June 22, 2026
10 filings cited on this page
Method: intel.velarion.ai/methodology
A report that fails to generate is refunded in full
Published by Velarion Company Intelligence
$1,500Get the executive brief
136 figures on this page: 127 cited to the filing that reported them, 9 calculated from figures it prints. See the citations
What changed from fiscal 2024 to fiscal 2025
The figures that moved, and by how much. Analysis of these figures is part of the Velarion platform.
Chief executive total compensation — Jay Duker: $5,954,807 → $5,568,352 (6.5% lower)
Say-on-pay support: 93.5% → 96.8% (3.3 points higher)
Frequently asked questions
Answers drawn from the data on this page.
Who is EyePoint's chief executive and what were they paid?
Jay Duker was paid $5,568,352 in total compensation as President and Chief Executive Officer for fiscal 2025. Duker's total moved 6.5% lower from the $5,954,807 reported for fiscal 2024.
What was EyePoint's say-on-pay result?
Shareholders supported the say-on-pay proposal with 96.8% of votes cast for or against in favor at the meeting held April 21, 2026 for fiscal 2025.
Executive compensation
Every element reported for each named executive officer, by fiscal year.
Fiscal 2024
| Officer | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension and deferred earnings | All other compensation | Total |
|---|---|---|---|---|---|---|---|---|
Jay Duker President and Chief Executive Officer | ◇ | — | ◇ | ◇ | ◇ | — | ◇ | ◇ |
Ramiro Ribeiro Chief Medical Officer | ◇ | ◇ | — | ◇ | ◇ | — | ◇ | ◇ |
George Elston Executive Vice President and Chief Financial Officer | ◇ | — | ◇ | ◇ | ◇ | — | ◇ | ◇ |
Fiscal 2025
| Officer | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension and deferred earnings | All other compensation | Total |
|---|---|---|---|---|---|---|---|---|
Jay Duker President and Chief Executive Officer | ◇ | — | ◇ | ◇ | ◇ | — | ◇ | ◇ |
George Elston Executive Vice President and Chief Financial Officer | ◇ | — | ◇ | ◇ | ◇ | — | ◇ | ◇ |
Ramiro Ribeiro Chief Medical Officer | ◇ | — | ◇ | ◇ | ◇ | — | ◇ | ◇ |
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero. A negative change in pension value is shown but, as the company reports it, not included in the total.
Outstanding awards
Awards still held at fiscal year end.
As disclosed at fiscal 2025 year end
| Officer | Award | Unvested units | Market value of unvested units | Exercise price | Expires |
|---|---|---|---|---|---|
| Ramiro Ribeiro | Option | ◇ | — | ◇ | — |
| Option | ◇ | — | ◇ | — | |
| RSU | ◇ | ◇ | — | — | |
| George Elston | Option | ◇ | — | ◇ | — |
| Option | ◇ | — | ◇ | — | |
| Option | ◇ | — | ◇ | — | |
| Option | ◇ | — | ◇ | — | |
| Option | ◇ | — | ◇ | — | |
| Option | ◇ | — | ◇ | — | |
| RSU | ◇ | ◇ | — | — | |
| Jay Duker | Option | ◇ | — | ◇ | — |
| Option | ◇ | — | ◇ | — | |
| Option | ◇ | — | ◇ | — | |
| Option | ◇ | — | ◇ | — | |
| Option | ◇ | — | ◇ | — | |
| RSU | ◇ | ◇ | — | — |
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero.
Director compensation
What each non-employee director was paid.
Fiscal 2025
| Director | Fees earned in cash | Stock awards | Option awards | Non-equity incentive | Pension and deferred earnings | All other compensation | Total |
|---|---|---|---|---|---|---|---|
Reginald Sanders | ◇ | — | ◇ | — | — | — | ◇ |
Göran Ando Board chair | ◇ | — | ◇ | — | — | — | ◇ |
Wendy DiCicco | ◇ | — | ◇ | — | — | — | ◇ |
Nancy Lurker | ◇ | — | ◇ | — | — | — | ◇ |
Karen Zaderej | ◇ | — | ◇ | — | — | — | ◇ |
Stuart Duty | ◇ | — | ◇ | — | — | — | ◇ |
Fred Hassan | ◇ | — | ◇ | — | — | — | ◇ |
John Landis | ◇ | — | ◇ | — | — | — | ◇ |
Jay Duker served on the board in fiscal 2025 and received no compensation for board service. Executive directors are typically paid through their executive roles, shown above.
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero.
Director fee schedule
The standing retainers and premiums the board pays, as published.
| Board cash retainer | ◇ |
| Total board retainer | ◇ |
| Audit committee chair | ◇ |
| Audit committee member | ◇ |
| Compensation committee chair | ◇ |
| Compensation committee member | ◇ |
| Nominating and governance chair | ◇ |
| Nominating and governance member | ◇ |
Disclosed peer group
The companies this board named as its compensation comparison group. The list is disclosure; the comparison is analysis.
Say-on-pay history
Shareholder support for the compensation program, by year.
| Year | Meeting | Support | Votes for | Votes against | Abstentions |
|---|---|---|---|---|---|
| 2025 | April 21, 2026 | = | ◇ | ◇ | ◇ |
| 2024 | April 23, 2025 | = | ◇ | ◇ | ◇ |
| 2023 | April 23, 2024 | = | ◇ | ◇ | ◇ |
| 2022 | April 21, 2023 | = | ◇ | ◇ | ◇ |
| 2021 | September 23, 2022 | = | ◇ | ◇ | ◇ |
| 2020 | April 26, 2021 | = | ◇ | ◇ | ◇ |
| 2018 | April 26, 2019 | = | ◇ | ◇ | ◇ |
| 2016 | December 15, 2017 | = | ◇ | ◇ | ◇ |
| 2015 | December 12, 2016 | = | ◇ | ◇ | ◇ |
What this page does not include
Everything above is a fact EyePoint disclosed, and it is free. Everything below is our analysis of those facts, and it is not.
Written compensation analysis
A read of the pay program as designed and as paid: incentive structure, goal rigor, the alignment between the committee's stated philosophy and what the numbers show.
Executive Compensation Report — $1,500Board and governance analysis
Committee composition, independence, director pay positioning, and the governance provisions read together rather than listed.
Board Governance Report — $1,200Realizable pay
What the awards above are actually worth today against what they were valued at on grant, and what the gap says about the pay-for-performance link.
Velarion IntelligenceAdviser switching and vote outcomes
Two datasets covering compensation-adviser changes and what followed a contested vote. Both are part of the Velarion platform.
Inquire about accessMultiple companies at once
Cross-company views, cohort screens, and data export across the industries we cover. This page is one company; the platform is all of them.
Velarion IntelligenceCitations
Every figure on this page is cited to the document that reported it. Select any figure to see its citation.
136 figures on this page: 127 cited to the filing that reported them, 9 calculated from figures it prints.
127 cited to the filing
9 calculated from the filing
Documents cited
- 0001193125-26-276688Item 5.07 Submission of Matters to a Vote of Security Holders
- 0001193125-26-182035EXECUTIVE OFFICER AND DIRECTOR COMPENSATION
- 0000950170-25-088169Item 5.07 Submission of Matters to a Vote of Security Holders
- 0000950170-24-075872Item 5.07 Submission of Matters to a Vote of Security Holders
- 0000950170-23-029066Item 5.07 Submission of Matters to a Vote of Security Holders
- 0000950170-22-024735Item 5.07 Submission of Matters to a Vote of Security Holders
- 0001564590-21-034107Item 5.07. Submission of Matters to a Vote of Security Holders.
- 0001193125-19-185970Item 5.07. Submission of Matters to a Vote of Security Holders.
- 0001193125-17-373598Item 5.07 Submission of Matters to a Vote of Security Holders
- 0001193125-16-795803Item 5.07 Submission of Matters to a Vote of Security Holders.
Cite this data
This page is free to cite. Attribution we ask for:
Velarion, “EyePoint executive compensation, FY2024–FY2025.” https://intel.velarion.ai/comp/EYPT (accessed 2026).
Short form: data: Velarion
The EyePoint brief, $1,500
Positioning against its disclosed peers, the governance read, incentive design, and the CD&A alignment analysis; the full peer table; a committee-ready PDF.
From $1,200 for the board report; $2,400 for both.
10 filings cited on this page
Method: intel.velarion.ai/methodology
A report that fails to generate is refunded in full
Published by Velarion Company Intelligence
Embed this data
A small, cited view of this data for your own page or newsletter. Every embed carries a visible link back here, so the attribution travels with it.
The headline figures, each with its citation.
Connect an AI assistant
Ask your own assistant about EyePoint and roughly 3,000 other US public companies, and get back the same figures on this page with the same citations. Free read access, no account. Add this to your assistant's connector settings.
Free to read and cite. Redistribution or bulk use of the dataset requires a data license. Talk to us about the data license.
Cite this data
APA
Velarion Company Intelligence. (2026). Velarion database: executive and board compensation data (Version 2026Q3) [Data set]. Zenodo. https://doi.org/10.5281/zenodo.22283854
BibTeX
@misc{velarionData2026,
author = {{Velarion Company Intelligence}},
title = {Velarion database: executive and board compensation data},
year = {2026},
version = {2026Q3},
doi = {10.5281/zenodo.22283854},
publisher = {Zenodo},
url = {https://doi.org/10.5281/zenodo.22283854}
}